GPT and urothelial carcinoma: Our finding is supported by Su et al. (2020), who, in a comprehensive meta-analysis, confirmed that a higher pretreatment AST/ALT ratio is significantly associated not only with inferior OS and CSS but also with higher likelihood of disease recurrence, including intravesical (bladder) recurrence, in urothelial carcinoma [21].